Efficacy and Safety of Jingling Oral Liquid for Children With ADHD: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial.

J Atten Disord

National Clinical Research Center for Mental Disorders & National Center for Mental Disorders, Beijing Anding Hospital, Capital Medical University, Beijing, China.

Published: September 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Objective: This study aims to verify the therapeutic efficacy and safety of a traditional Chinese medicine, Jingling Oral Liquid, in treating ADHD through a multicenter, randomized, double-blind, placebo-controlled trial (ChiCTR-IPR-17012293).

Method: Eighty-five children with ADHD underwent 8 weeks of strictly monitored treatment. Forty children (8.2 ± 2.1 years old, nine girls) were randomly assigned to be treated with Jingling Oral Liquid (Liaoning Dongfangren Pharmaceutical Co., Ltd.), and 41 children (8.6 ± 2.5 years old, six girls) received placebo treatment.

Results: Significant improvement was observed in the total score of ADHD rating scale (-4.8, 95% CI [-8.4, -1.1],  = .011) and in the hyperactivity/impulsivity score (-3.0, 95% CI [-4.8, -1.1],  = 0.002) for the Medicine group compared with the Placebo group, but not for inattention score (-1.9, 95% CI [-4.0, 0.2],  = 0.078). No significant changes were observed in the physiological indicators of the children pre- and post-treatment, and no definite drug-related adverse reactions were reported.

Conclusion: Jingling Oral Liquid has shown efficacy in managing ADHD, specifically targeting hyperactivity and impulsivity symptoms, and maintaining a favorable safety profile.

Download full-text PDF

Source
http://dx.doi.org/10.1177/10870547251365676DOI Listing

Publication Analysis

Top Keywords

jingling oral
16
oral liquid
16
efficacy safety
8
children adhd
8
adhd multicenter
8
multicenter randomized
8
randomized double-blind
8
double-blind placebo-controlled
8
children
5
adhd
5

Similar Publications

Efficacy and Safety of Jingling Oral Liquid for Children With ADHD: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial.

J Atten Disord

September 2025

National Clinical Research Center for Mental Disorders & National Center for Mental Disorders, Beijing Anding Hospital, Capital Medical University, Beijing, China.

Objective: This study aims to verify the therapeutic efficacy and safety of a traditional Chinese medicine, Jingling Oral Liquid, in treating ADHD through a multicenter, randomized, double-blind, placebo-controlled trial (ChiCTR-IPR-17012293).

Method: Eighty-five children with ADHD underwent 8 weeks of strictly monitored treatment. Forty children (8.

View Article and Find Full Text PDF
Article Synopsis
  • - Endoscopic mucosal resection (EMR), developed in 1973, is commonly used to treat polyps, small adenomas, and early-stage cancers in the gastrointestinal tract.
  • - Despite its proven safety, EMR can lead to complications, as illustrated by a case where a patient developed acute appendicitis following the procedure.
  • - It is important to carefully monitor patients who experience postoperative abdominal pain after colorectal EMR, particularly those with potential fecaliths near the appendix.
View Article and Find Full Text PDF

Objective: To observe the clinical effect of Jingling oral liquid (JLOL) in treating infertile patients with varicocele after varicocelectomy.

Methods: Sixty patients were randomly divided into two groups, the 30 patients in the treated group treated by JLOL, and the 30 in the control group treated with intramuscular injection of human chorionic gonadotropine (hCG).

Results: The pregnant rate of patient's wife in the treated group was 76.

View Article and Find Full Text PDF

A study on the localization and distribution of GnRH and its receptor in rat submaxillary glands by immunohistochemical, in situ hybridization and RT-PCR.

Life Sci

May 2003

Department of Reproduction of Nanjing Jingling Hospital, Clinical School of Medical College, Nanjing University, No.305 East Zhongshan Road, 210002, Nanjing, People's Republic of China.

Article Synopsis
  • The study focused on the rat submaxillary gland to find GnRH and its receptors, using methods like immunohistochemistry and RT-PCR.
  • Findings indicated that both GnRH and its receptors were found together in the gland's epithelial cells, suggesting they are localized in the same areas.
  • The results imply that the rat submaxillary gland can produce GnRH and its receptors, which might play a role in regulating the gland's functions through local signaling mechanisms.
View Article and Find Full Text PDF